Analysts Stocks

      Barclays Downgrades DOCS to Equal-Weight, PT $20

      Glen Santangelo at Barclays trimmed their price target on DOCS to $20 on May 15, downgrading the rating to Equal-Weight from Overweight.

      AnaChart has tracked 11 price-target calls from Glen on DOCS. The stock’s price reached the target in 9 of 11 of those calls.

      The rating count on DOCS runs 14 Buy, 5 Hold right now. The target range spans Stan Berenshteyn at Wells Fargo ($18) to Scott Berg at Needham ($67). DOCS last closed at $22.01.

      DOCS price target chart: Barclays cuts to $20
      Glen Santangelo’s DOCS target history against the street high, street low and the stock price. Each dot marks a dated call.

      The $20 target is 9% below the stock’s $22.01 close.

      FAQ

      What is Barclays’s price target on DOCS?

      Barclays’s Glen Santangelo has a $20 target on DOCS, rated Equal-Weight, set May 15, 2026.

      How often have Glen Santangelo’s DOCS price targets been reached?

      AnaChart has tracked 11 price-target calls from Glen Santangelo on DOCS; the stock reached the target in 9 of them (82%).

      What is the analyst view on DOCS?

      Coverage is split 14 Buy / 5 Hold / 0 Sell, with targets from $18 (Wells Fargo) to $67 (Needham).